The S&P/ASX 200 Index (ASX: XJO) was out of form last week and tumbled lower. The benchmark index lost 0.7% of its value over the five days to end at 7,304 points.
Four ASX 200 shares that didn't let that hold them back are listed below. Here's why they were the best performers on the index last week:
Image source: Getty Images
Nanosonics Ltd (ASX: NAN)
The Nanosonics share price was the best performer on the ASX 200 last week with a gain of 11.7%. This was despite there being no news out of the infection prevention company. This latest gain means the Nanosonics share price is now up an impressive 22% since the start of December. One broker that still thinks its shares can go higher is Morgans. It currently has an add rating and $6.97 price target on them.
WiseTech Global Ltd (ASX: WTC)
The WiseTech share price wasn't far behind with a 10.3% gain. Once again, this was despite there being no news out of the logistics solutions company. Though, with the company's CEO continuing to sell down his holding last week, investors could be taking this as a positive signal. The theory being that if WiseTech was not at least performing in line with guidance, he wouldn't be able to sell shares. WiseTech is forecasting strong sales and operating earnings growth in FY 2022.
Charter Hall Group (ASX: CHC)
The Charter Hall share price was on form last week and charged 9.5% higher. Investors were buying this property company's shares following the release of a strong update on Monday. That update saw Charter Hall upgrade its guidance for FY 2022 a second time. This went down well with the team at Macquarie. In response, the broker retained its outperform rating and lifted its price target on the company's shares to $22.90.
Omni Bridgeway Ltd (ASX: OBL)
The Omni Bridgeway share price was a solid performer and rose 9.4% over the period. Last week the class action funder announced the completion of two investments, with expected income generation of approximately $18 million. In addition to this, Goldman Sachs recently reiterated its conviction buy rating and lofty $5.35 price target.
